InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Nishar Dipchand. Director active across 2 companies, notably Vir Biotechnology, Inc.. Cumulatively, 9 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €95k. Activity tracked since 21 May 2021. The latest transaction was disclosed on 28 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Nishar Dipchand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
16,500 股0Class A Common StockSEC:0001519500-26-000004:0
10,660 股@ US$2.18250.020% mcap21.5% 占其流量Class A Common StockSEC:0001519500-26-000002:0
20,500 股0Class A Common StockSEC:0001415889-25-019575:0
30,253 股@ US$2.080373.0% 占其流量Class A Common StockSEC:0001415889-25-017434:0
12,109 股@ US$1.7765100.0% 占其流量Class A Common StockSEC:0001415889-24-017505:0
58,178 股0Class A Common StockSEC:0001415889-24-016923:0
23,443 股0Class A Common StockSEC:0001209191-23-038197:0
9,945 股0Class A Common StockSEC:0001209191-22-038127:0
3,374 股0Common StockSEC:0001209191-21-035712:0
9 条申报中的 9 条
About Nishar Dipchand
Nishar Dipchand is a declarant and a Director at Seer, Inc. (XNAS) and Vir Biotechnology, Inc. (XNAS). He has 6 filings in total, and across the 6 recent filings held, the reported sell amount is EUR 20032, with Attribution as the modal transaction nature, from 2021-05-25 to 2024-06-18. The largest listed filing is a sale of EUR 20031.63890054876 at Seer, Inc. on 2024-06-18.
